Array BioPharma To Present At The Morgan Stanley 2014 Global Healthcare Conference
BOULDER, Colo., Sept. 3, 2014 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Morgan Stanley 2014 Global Healthcare Conference in New York City. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.
| Event: |
Morgan Stanley 2014 Global Healthcare Conference |
| Presenter: |
Ron Squarer, Chief Executive Officer |
| Date: |
Wednesday, September 10, 2014 |
| Time: |
12:55 p.m. Eastern Time |
| Location: |
Grand Hyatt New York |
| Webcast: |
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Seven Phase 3 or pivotal studies are already in progress, or are planned to begin this year. These programs include the wholly-owned hematology drug, filanesib (ARRY-520) for multiple myeloma and two partnered cancer drugs, selumetinib (AstraZeneca) and binimetinib (MEK162 / Novartis). For more information on Array, please go to www.arraybiopharma.com.
| CONTACT: |
Tricia Haugeto |
| Array BioPharma Inc. |
|
| 303-386-1193 |
|
Logo - http://photos.prnewswire.com/prnh/20121029/LA02195LOGO
SOURCE Array BioPharma
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article